(Q43482749)
Statements
Increase in lifetime adverse drug reactions, service utilization, and disease severity among patients who will start COX-2 specific inhibitors: quantitative assessment of channeling bias and confounding by indication in 6689 patients with rheumatoid arthritis and osteoarthritis (English)
Frederick Wolfe
1 reference
Nancy Flowers
Thomas A Burke
Lester M Arguelles
Dan Pettitt